Mobile

A randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of oral RSV604 in healthy adults experimentally infected with respiratory syncytial virus

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000790-38

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the antiviral activity of RSV604, given orally, on nasal RSV load, as measured by RT-PCR, in healthy adults experimentally inoculated with a challenge virus of RSV. - To evaluate the safety of RSV604 when given on a 5-day regimen to infected healthy adults

Critère d'inclusion

  • infection with respiratory syncytial virus

Liens